Wildlife thrives in Chernobyl's exclusion zone. Grey wolves there show remarkable genetic changes. These wolves have developed resistance t...

India has proudly introduced Nafithromycin, its first homegrown antibiotic, tackling stubborn respiratory infections with groundbreaking ef...

Bayer, through its subsidiary Viralgen, is advancing cell and gene therapies (CGT) to cure diseases like Parkinson's, oncology, cardiovascu...

Huntington's disease has been successfully treated for the first time with an experimental gene therapy called AMT-130, which uses a clever...

Qure stock: UniQure's stock soared after AMT-130 gene therapy demonstrated a statistically significant slowing of Huntington's disease prog...

Huntington’s disease is a rare, hereditary neurological condition causing progressive neuron loss, movement challenges, cognitive decline, ...

Doctors have successfully slowed Huntington’s disease for the initial time with the deployment of gene therapy named AMT-130, administered ...

Global HIV research indicates a potential cure for children through early antiretroviral therapy (ART). A small group of HIV-infected infan...

ImmunoAct, an Indian cell and gene therapy company, has achieved profitability in its first full year, generating ₹62 crore in revenue and ...

In an amazing breakthrough in the medical field, using gene therapy by doctors in the UK helped a British girl get her hearing ability back.

The high cost of Zolgensma, a one-time gene therapy used to treat spinal muscular atrophy (SMA) in children under two, is to limited patien...

The chemical cocktails developed by the researchers consist of a combination of five to seven agents, some of which are already prescribed ...

Scientists are hopeful that disorders like Alzheimer's, Parkinson's, etc. will be treatable in the future.

Regulatory and clinical development expertise and the might to take products through the commercialization stages offer a natural edge to b...

The U.S. Food and Drug Administration on Wednesday approved a radical new one-time treatment from the Swiss drugmaker, weeks earlier than e...

The study opens the door for therapies which suppress the gene and for screening that would pick up the risk early.

The discovery hinges on the fact that some cancers are caused by disruptions to specific signalling pathways found within cells.